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Abstract
Background: Patients with pelvic malignancies often receive radiosensitising chemotherapy with radiotherapy to
improve survival; however, this is at the expense of increased normal tissue toxicity, particularly in elderly patients.
Here, we explore if an alternative, low-cost, and non-toxic approach can achieve radiosensitisation in mice transplanted
with human bladder cancer cells. Other investigators have shown slower growth of transplanted tumours in mice fed
high-fibre diets. We hypothesised that mice fed a high-fibre diet would have improved tumour control following
ionising radiation (IR) and that this would be mediated through the gut microbiota.
Results: We investigated the effects of four different diets (low-fibre, soluble high-fibre, insoluble high-fibre, and mixed
soluble/insoluble high-fibre diets) on tumour growth in immunodeficient mice implanted with human bladder cancer
flank xenografts and treated with ionising radiation, simultaneously investigating the composition of their gut
microbiomes by 16S rRNA sequencing. A significantly higher relative abundance of Bacteroides acidifaciens was
seen in the gut (faecal) microbiome of the soluble high-fibre group, and the soluble high-fibre diet resulted in
delayed tumour growth after irradiation compared to the other groups. Within the soluble high-fibre group,
responders to irradiation had significantly higher abundance of B. acidifaciens than non-responders. When all
mice fed with different diets were pooled, an association was found between the survival time of mice and
relative abundance of B. acidifaciens. The gut microbiome in responders was predicted to be enriched for
carbohydrate metabolism pathways, and in vitro experiments on the transplanted human bladder cancer cell
line suggested a role for microbial-generated short-chain fatty acids and/or other metabolites in the enhanced
radiosensitivity of the tumour cells.
Conclusions: Soluble high-fibre diets sensitised tumour xenografts to irradiation, and this phenotype was
associated with modification of the microbiome and positively correlated with B. acidifaciens abundance. Our
findings might be exploitable for improving radiotherapy response in human patients.
Keywords: Gut microbiome, Dietary fibre, Inulin, Cellulose, Radiotherapy, Radiosensitisation, Pelvic tumour, B.
Acidifaciens, Parabacteroides
© The Author(s). 2020, corrected publication 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: anne.kiltie@oncology.ox.ac.uk
†Chee Kin Then and Salome Paillas contributed equally to this work.
1CRUK/MRC Oxford Institute for Radiation Oncology, Department of
Oncology, University of Oxford, Old Road Campus Research Building, Off
Roosevelt Drive, Oxford OX3 7DQ, UK
Full list of author information is available at the end of the article
Then et al. BMC Biology          (2020) 18:102 
https://doi.org/10.1186/s12915-020-00836-x
Background
Patients with pelvic tumours, including bladder, cervix,
and rectal cancers, who are receiving radiotherapy are
often given additional radiosensitising chemotherapy to
improve cure rates, at the expense of increased toxicity
in local organs and tissues [1, 2]. With an ageing popula-
tion, new approaches to radiosensitisation are urgently
required. One such approach might be to modify the in-
take of dietary fibre by supplements before and during
radiotherapy or current standard chemoradiation sched-
ules, which would be a very cost-effective strategy, not
expected to add to normal tissue toxicity [3, 4].
Wei et al. showed slower growth rates of subcutaneous
lymphoma xenografts in mice fed a high-fibre diet (8%)
compared to mice on a low-fibre diet, with similar find-
ings in both immune-deficient and immune-competent
models [5]. This was associated with increased plasma
and tumour butyrate levels, but the authors did not in-
vestigate the effects of the diet on the gut microbiome.
Dietary fibre manipulation can very rapidly alter the
human gut microbiome, with changes in faecal short-chain
fatty acid (SCFA) levels seen only 1 day after the diet
reaches the distal gut [6]. Dietary fibre can also mediate sys-
temic immune effects [7], as can the microbiota-derived
SCFAs [8, 9]. Furthermore, dietary fibre structures align
with phenotypes of specific microbes that differ in their
metabolic pathways [10]. SCFAs are known to confer anti-
cancer effects [5, 8, 9]. Other metabolites including small
intermediate and end by-products of endogenous metabolic
pathways, products of microbe-host co-metabolism, and
exogenous signals arising from diet, drugs, and other envir-
onmental stimuli might also be important [11].
We hypothesised that systemic effects of altered metab-
olites secreted by gut bacteria on tumours, due to dietary
fibre modification, could be exploited in conjunction with
ionising radiation (IR) to achieve radiosensitisation.
The aims of this study were to examine the impact of
the diet on the microbiome before and after irradiation
and to correlate diet-induced microbiome changes with
tumour growth and response to radiation treatment.
Results
The environmental microbiome had minimal impact on
gut microbiome analysis
Female CD1 nude mice were injected subcutaneously
with RT112 bladder carcinoma cells, and at the same
time, they commenced a modified diet, namely one of
the following: low dietary fibre (0.2% cellulose), low fibre
with butyrate in drinking water, high soluble fibre (10%
inulin), high insoluble fibre (10% cellulose), and high
mixed fibre (5% cellulose, 5% inulin) (Fig. 1a and Add-
itional file 1: Table S1). We quantified bacterial loads
using PCR and gel electrophoresis, compared to known
numbers of E. coli colony-forming units (CFUs). Our
mouse samples contained more than 104 bacterial CFUs
which appeared to override contaminating species in the
sample microbial communities (Fig. 1b). The PBS nega-
tive control was processed from the start of the DNA ex-
traction identically to the luminal contents and tissue
samples. The amount of nucleic acid detected in the
PBS negative controls was extremely low, compared to
that in the gut microbiota (Fig. 1c). Furthermore, the
community microbiome in this negative control differed
markedly from the gut microbiome of the mice (Fig. 1d).
Therefore, the environmental microbiome had minimal
impact on the analysis of the gut microbiomes of inter-
est in this study.
The landscape, diversity, and enrichment of bacterial taxa
in the gut microbiome samples collected when the
tumours reached 50mm3
In samples collected when the tumours reached 50mm3
and 350 mm3, the faecal (hereinafter referred to as “gut
microbiome”) and caecal microbiomes were found to
have similar bacterial components (Additional file 1:
Figure S1). In mice culled when their tumours
reached 50 mm3, butyrate levels in the faeces, mea-
sured by high-performance liquid chromatography
(HPLC), were found to be in the millimolar range
and were generally higher in the low fibre with butyr-
ate and high soluble fibre groups (p = NS; Additional
file 1: Figure S2A). The mean time for tumours to
reach 50 mm3 was 12.8 ± 1.4 days (Additional file 1:
Figure S2B).
In faeces collected from culled mice when the tumours
reached 50mm3, abundance analysis revealed the five
bacterial taxa with the highest abundance were Bacter-
oides acidifaciens, Parabacteroides, Akkermansia mucini-
phila, Lachnospiraceae, and S24-7 (Fig. 2a). In terms of
alpha diversity, the soluble high-fibre group had a lower
Shannon’s index (p < 0.001) (Fig. 2b). This could be due
to the higher abundance of B. acidifaciens, which low-
ered the diversity within groups. In terms of beta diver-
sity, principal coordinate analysis showed a notable
cluster effect among different groups, which indicates
that samples within groups were more similar to each
other than to those from the other groups (Fig. 2c). This
suggested that the gut microbiome was indeed modified
in this study, which might be a diet-effect or a cage-
effect (see later). Regarding the abundance of specific
taxa in different diet groups (Fig. 2d), the high soluble
fibre diet significantly increased B. acidifaciens abun-
dance (p < 0.001); the low-fibre diet increased Parabac-
teroides abundance (p < 0.001), the low-fibre diet with
added butyrate increased Akkermansia muciniphila
abundance (p < 0.001), and the high mixed fibre diet in-
creased Lachnospiraceae abundance (p = 0.005).
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The landscape, diversity, and enrichment of bacterial taxa
in the gut microbiome samples collected when the
tumours reached 350mm3
When the tumours reached 350mm3, abundance analysis
of the gut microbiome of both IR and non-IR cohorts re-
vealed that the top 6 bacterial taxa with the highest
abundance were S24-7, Akkermansia muciniphila, Bacter-
oides, Lachnospiraceae, Clostridiales, and B. acidifaciens
(Fig. 3a). In terms of alpha diversity, the soluble HF group
had a significantly lower Shannon’s index (p < 0.001 for
the Kruskal-Wallis test) (Fig. 3b). In terms of beta diver-
sity, principal coordinate analysis using the Bray-Curtis
Fig. 1 The environmental microbiome had minimal impact on gut microbiome analysis. a Two microbiomes were analysed from the intestinal
tract, namely faecal and caecal content samples collected when tumours reached 50mm3 and 350mm3, respectively. b Quantification of
bacterial load from different tissue and luminal contents from mice, with E. coli (1 × 102, 1 × 104, 1 × 106 CFUs) as controls (n = 1 mouse). c
Comparison of the total amount of nucleic acid quantified by PicoGreen assay in all samples collected when the tumours reached 50mm3 and
350mm3. d Common bacterial taxa at the species level in 4 samples of PBS, as negative controls of DNA extraction by 16S rRNA sequencing
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dissimilarity showed a notable clustering effect among dif-
ferent groups, which indicates that samples within groups
were more similar to each other than to those from the
other groups (Fig. 3c). The composition of the gut micro-
biome continued to evolve on the diets to the time the tu-
mours reached 350mm3, regardless of whether the mice
were irradiated or not. The taxonomic cladogram of LEfSe
(linear discriminant analysis effect size) of the gut micro-
biome showed that the high soluble fibre diet increased
relative abundance of S24-7 (Additional file 1: Figure S3).
B. acidifaciens, an acetate-producing bacterium [12, 13],
was found to be of highest abundance in all but the LF
diet group at 50mm3, but by 350mm3 was evenly distrib-
uted across the different diet groups, except the soluble
HF group treated with radiation (p = 0.200 for the
Kruskal-Wallis test) (Fig. 3d).
Bacteroidales S24-7 was the highest abundance bacter-
ial taxa in the second cohort. Its relative abundance was
Fig. 2 Dietary fibre shapes the baseline gut microbiome when tumours reached 50mm3. a Stacked bar plot of phylogenetic composition of
common bacterial taxa at the species level when tumours reached 50mm3. Faeces were collected from mice fed with low-fibre, low-fibre with butyrate,
high mixed fibre, high insoluble fibre, and high soluble fibre diets (n= 3 for each group). b Shannon’s index of gut microbiomes by the Kruskal-Wallis test.
Error bars represent the interquartile range of diversity scores. c Principal coordinate analysis of gut microbiomes using the Bray-Curtis dissimilarity. A
notable clustering effect by diet was seen in the gut microbiome. d Differentially abundant taxa when the tumours reached 50mm3. All comparisons
among different diet groups were performed by the Kruskal-Wallis test and Dunn’s multiple comparison tests. All tests compared each median with the
“control” denoted. The diet with the highest abundance of taxa was denoted as the control. *p< 0.05; **p< 0.01; ***p< 0.001
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significantly higher in the mixed HF and soluble HF
groups compared to the LF and insoluble HF groups
(p = 0.001 for the Kruskal-Wallis test) (Fig. 3e).
Soluble high fibre causes increased growth delay in
irradiated bladder cancer cell xenografts
To investigate the effect of different diets on the tumour
response in mice irradiated when the tumour had grown
to 50 mm3, tumour growth was monitored to 350mm3.
Fig. 3 Composition of the gut microbiome when tumours reached 350mm3. a Stacked bar plot of the phylogenetic composition of common
bacterial taxa at the species level when tumours reached 350mm3. Samples were collected from mice fed with low-fibre, high mixed fibre, high insoluble
fibre, and high soluble fibre diets (n= 8 for each group). b–e Results for irradiated mice only. b Shannon’s index of gut microbiomes by the Kruskal-Wallis
test. Error bars represent the interquartile range of diversity scores. c Principal coordinate analysis of gut microbiomes using the Bray-Curtis dissimilarity.
Relative abundance of d B. acidifaciens and e Bacteroidales S24-7 in mice with or without irradiation. *p< 0.05; **p< 0.01; ***p< 0.001
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Slopes of the tumour growth curves were obtained using
linear regression to indicate the tumour progression rates
(Fig. 4a). The high soluble fibre diet group had the slowest
tumour growth rate. The slopes were 4.4 ± 1.3 for LF,
16.1 ± 1.7 for mixed HF, 28.7 ± 1.3 for insoluble HF, and
0.4 ± 1.5 for soluble HF (Fig. 4a and Additional file 1: Figure
S4 for individual irradiated mouse tumour growth curves).
The Kaplan-Meier survival curves for time to treble tumour
volume showed that the soluble HF group had the longest
median survival time (7.5 days for LF, 7 days for mixed HF,
10 days for insoluble HF, 11.5 days for soluble HF; p =
0.005, log-rank test) (Fig. 4b).
Among the eight mice fed the soluble high-fibre diet,
four mice were classified as responders as, using linear
regression, they had shallower slopes to the tumour
growth curves, namely 7.3 ± 1.2, − 0.9 ± 0.6, − 4.8 ± 0.5,
and − 5.2 ± 0.9. The other four mice were classified as
non-responders with steeper slopes to the tumour
growth curves, namely 34.6 ± 3.0, 31.1 ± 2.6, 23.3 ± 1.0,
and 33.8 ± 2.9 (Fig. 4c). In terms of alpha diversity, there
was no significant difference in Shannon’s index between
Fig. 4 Soluble high fibre causes increased growth delay in irradiated bladder cancer cell xenografts, and responses are influenced by gut
microbiota composition. a Tumour growth in RT112 flank xenografts irradiated with 6 Gy IR, in mice fed low-fibre, high mixed fibre, high
insoluble fibre, and high soluble fibre diets (n = 8 for each group). Tumour curve slopes were calculated by linear regression to represent tumour
growth rates and compared by ANOVA. b The Kaplan-Meier survival curves for mice showing plots of time to treble tumour volume. c Mice in
the soluble HF group were stratified into responders and non-responders based on tumour radiation response. d Shannon’s index of gut
microbiota in responders and non-responders by the Kruskal-Wallis test. Error bars represent the interquartile range of diversity scores. e Principal
coordinate analysis of gut samples (n = 8) in the soluble HF group by response using the Bray-Curtis dissimilarity
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responders and non-responders (Fig. 4d). In terms of
beta diversity, principal coordinate analysis of the Bray-
Curtis dissimilarity showed the gut microbiomes of re-
sponders and non-responders were more similar within
groups than between groups (Fig. 4e).
Differences in composition of the gut microbiome
between responders and non-responders
Linear discriminant analysis showed that mice responding
to the soluble high-fibre diet with a slower tumour growth
rate were enriched with Bacteroidaceae (f), Flavobacter-
ium (g), Flavobacteriales (o), Lactococcus (g), Streptococcus
(g), Streptococcaceae (f), Allobaculum (g), and Erysipelotri-
chales (o). The non-responding tumour-bearing mice were
enriched with Bifidobacterium (g), Bidifobacteriaceae (f),
Bifidobacteriales (o), Parabacteroides (g), Porphyromona-
daceae (f), Lactobacillus (g), Lactobacillaceae (f), and Lac-
tobacillales (Fig. 5a). In terms of effect size, B. acidifaciens
(sp) and Bacteroidaceae (f) had the largest enrichment in
responders, and Parabacteroides (g) and Porphyromona-
daceae (f) had the largest enrichment in non-responders
(Fig. 5b). To further explore these findings, the discrete
false-discovery rates within all taxonomic levels were cal-
culated (Fig. 5c). In responders, B. acidifaciens species and
the Allobaculum genus and in non-responders Lactobacil-
lus and Parabacteroides genera had p values < 0.05 The B.
acidifaciens abundance was significantly higher in re-
sponders than that in non-responders (p = 0.029 (Fig. 5d),
while the Bacteroidales S24-7 abundance was similar be-
tween responders and non-responders in the soluble HF
group (p = 0.200) (Fig. 5e).
Metagenomics functional prediction of the gut
microbiome by response in the soluble HF group and
in vitro functional effects of short-chain fatty acids
Functional prediction at KEGG (Kyoto Encyclopedia of
Genes and Genomes) pathway level 2 revealed that the
gut microbiome in responders was enriched for carbohy-
drate metabolism pathways and in non-responders for
membrane transport pathways (Fig. 5f). For carbohydrate
metabolism, the pathway with the highest level of enrich-
ment, statistical analysis showed that responders had a sig-
nificantly higher level than non-responders (Fig. 5g).
Short-chain fatty acids (SCFAs), including acetate, propi-
onate, and butyrate, are major products of fibre fermenta-
tion by the gut microbiota. We showed that all three
SCFAs increased histone acetylation (p = 0.014 for 10mM
acetate, p = 0.004 for 10mM propionate, p < 0.001 for 10
mM butyrate; Fig. 5h) and tend to increase radiosensitivity
(p =NS for acetate, p =NS for propionate, p = 0.002 for
butyrate in 8 Gy; Fig. 5i) of RT112 bladder cancer cells.
Single SCFAs reduced cell proliferation (Fig. 5j), while a
physiological SCFA mixture conferred a stronger
phenotype (Fig. 5j, purple bar) which was shown in a
time-dependent pattern as well (Additional file 1: Figure
S5A).
To validate the anti-tumoural effects of B. acidifaciens, we
treated the bladder tumour cells with bacterial supernatants
of B. acidifaciens and its cross-feeding with L. plantarum,
and compared their effects with Bifidobacterium (acetate-
producer) and L. plantarum (lactate-producer). Bacterial
supernatants of B. acidifaciens and its cross-feeding with L.
plantarum significantly increased cytotoxicity of bladder
tumour cells compared to the other supernatants in day 2
(Fig. 5k) and in day 3 (Additional file 1: Figure S5B).
Correlation between the abundance of B. acidifaciens or
Parabacteroides genus and mouse survival time in IR and
non-IR cohorts
As B. acidifaciens was the “top hit” for responders and
the Parabacteroides genus was one of the top two “hits”
for non-responders in the soluble HF group, we explored
how specific bacterial taxa affected mouse survival time.
The correlation between B. acidifaciens abundance and
time to culling was investigated across the diet groups.
Some mice in the non-IR cohort lived as long as those
in the IR cohort, i.e. > 40 days, which may be a reflection
of 6 Gy being a relatively low dose of radiation. In the IR
cohort, the time of culling positively correlated with B.
acidifaciens abundance (R2 = 0.528, p < 0.001). However,
a similar correlation was not seen in the non-IR cohort
(R2 = 0.085, p = 0.357) (Additional file 1: Figure S6A).
Using the time for tumours to treble in volume as the
outcome measure, mice with high B. acidifaciens abun-
dance had a significantly prolonged median survival time
(log-rank test, p < 0.001) (Fig. 6a). A similar finding was
seen in the IR cohort (p = 0.003), but not in the non-IR
cohort (p = 0.236). In the IR cohort, the time to culling
negatively correlated with the abundance of Parabacter-
oides genus (Additional file 1: Figure S6B; R2 = 0.164,
p = 0.022). However, a similar correlation was not seen
in the non-IR cohort (R2 = 0.084, p = 0.360). Mice in the
low Parabacteroides genus abundance group had no sig-
nificant difference in median time to treble in volume
compared to the high abundance group (log-rank test,
p = 0.374) (Fig. 6b). B. acidifaciens (p = 0.200 for the
Kruskal-Wallis test) and Parabacteroides genus (p =
0.005 for the Kruskal-Wallis test) abundance was evenly
distributed among all cages, which suggested that the ex-
istence of these taxa in the gut microbiome was not a
cage-specific effect (Additional file 1: Figure S7 and
Additional file 1: Table S2).
Discussion
To date, the literature studying the effects of dietary
fibre intake or manipulation of the gut microbiota on
tumour growth is limited. Wei et al. showed that dietary
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Fig. 5 Differences in composition of the gut microbiome between responders and non-responders. a Taxonomic cladogram from LEfSe showing
differences among taxa between responders and non-responders in the soluble HF group. Dot size is proportional to the abundance of the
taxon. b Linear discriminant analysis (LDA) scores computed for differentially abundant taxa in the microbiomes of responders (green) and non-
responders (red). Length indicates the effect size associated with a taxon, p = 0.05 for the Kruskal-Wallis test. c Discrete false-discovery rate of
different abundant taxa in responders and non-responders in the soluble HF group. Differential abundance within all taxonomic levels in
responders versus non-responders by Mann-Whitney U test. Dots are overlapping between Bacteroides acidifaciens and Allobaculum, and between
Lactobacillus and Parabacteroides. Relative abundance of d B. acidifaciens and e Bacteroidales S24-7 and in responders and non-responders in the
soluble HF group. f, g Metagenomic functional prediction by PICRUSt of the gut microbiome in responders (n = 4) and non-responders (n = 4) in
the soluble HF group with reference to the KEGG database level 2. Columns represent mice (responders, orange; non-responders, blue), and rows
represent enrichment of predicted KEGG pathways (red, low enrichment; yellow, medium enrichment; blue, high enrichment). h Western blot
analysis of histone acetylation levels of RT112 cells treated with SCFAs (N = 3). i Linear quadratic survival curves of IC10-treated RT112 cells with
receiving irradiation of 0–8 Gy (N = 3). j Cell survival analysis of RT112 cells treated with single SCFA and combined SCFAs mixture (N = 3).
Combined (purple bar) denotes SCFA mixture of 10 mM acetate, 5 mM propionate, and 1.7 mM butyrate. k Reduced cell survival of RT112 cells by
bacterial supernatants at day 2 (N = 1). BA+FP denotes the cross-feeding of B. acidifaciens and L. plantarum, while Bif+FP denotes the cross-feeding
of Bifidobacterium and L. plantarum. *p < 0.05; **p < 0.01; ***p < 0.001
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fibre and the associated butyrate production reduced
subcutaneous lymphoma tumour growth with associated
upregulation of histone 3 acetylation [5]. Hardman et al.
found slower growth of breast cancer xenografts in mice
fed with fish oil concentrate [14]. In contrast, Cougnoux
et al. found that colibactin-producing E. coli enhanced
tumour growth of colon cancer xenografts [15].
In this study, faecal and caecal microbiomes were in-
vestigated in mice fed the following: low-fibre diet, low-
fibre diet with butyrate, high mixed fibre diet, high
Fig. 6 Abundance of OTUs within the gut microbiome is predictive of response to ionising irradiation. The Kaplan-Meier (KM) plots of time for
tumours to treble in volume, whole cohorts, IR cohorts, and non-IR cohorts, based on a B. acidifaciens or b Parabacteroides genus abundance in
IR and non-IR cohorts from different diet groups combined. Comparison KM plots by log-rank test in mice with high abundance (green; relative
abundance > 0.1), intermediate abundance (red; 0.1 > relative abundance > 0.01), or low abundance (blue; 0.01 > relative abundance) of B.
acidifaciens in all, IR, and non-IR cohorts. For Parabacteroides genus, relative abundance more than or equal to 0.01 was classified as high (blue),
while less than 0.01 was classified as low (green)
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insoluble fibre (cellulose) diet, and high soluble fibre
(inulin) diet, and profiles of both microbiomes were cor-
related. The gut microbiomes were shaped by the differ-
ent modified diets within 2 weeks, and homogeneous
gut microbiomes were seen in samples within groups. A
distinct bacterial taxon was seen in each group: enrich-
ment of B. acidifaciens in soluble HF, Parabacteroides in
LF, Akkermansia muciniphila in LF with butyrate, and
Lachnospiraceae in mixed HF.
The tumours were irradiated when they reached a vol-
ume of 50 mm3 (with no effect on diet on the time to
reach this point) and monitored until they reached 350
mm3. During the course of the study, all mice developed
an increased relative abundance of S24-7 family bacteria,
thus indicating that their gut microbiomes had altered
over the tumour growth period. Although the gut micro-
biomes became more heterogeneous, a notable cluster
effect still existed in samples within groups. Mice
responding to radiation in the soluble HF group were
enriched with B. acidifaciens, and non-responding mice
were enriched with the Parabacteroides genus.
A predictive metagenomics study of the gut micro-
biome in responders was enriched for carbohydrate me-
tabolism pathways. This implies a higher level of fibre
fermentation occurring in responders, reflecting the se-
lection of bacteria more able to ferment carbohydrates.
This could result in more SCFA production in the fae-
ces. Both butyrate and propionate have been proposed
to increase histone deacetylase inhibition [16], which is a
known mechanism of cellular radiosensitisation [17, 18].
In this study, we demonstrated that these phenotypes
exist in bladder cancer cells (Fig. 5h, i). Furthermore,
in vitro studies showed that SCFA reduced cell prolifera-
tion in liver cancer [19], induced apoptosis in lung can-
cer [20], and did both in breast cancer [21]. Vecchia
et al. found that acetate and propionate potentiated the
anti-cancer effects of butyrate in leukaemic, cervical
adenocarcinoma, melanoma, and breast cancer cells
[22]. We demonstrated similar findings in bladder
cancer cells in this study (Fig. 5j and Additional file 1:
Figure S5A). Altogether, these data are supportive of
carbohydrate metabolism or SCFA production being im-
portant in enhancing anti-cancer effects, including
radiosensitisation.
When the mice from different diet groups were
pooled, B. acidifaciens abundance was positively corre-
lated with survival time, and mice with high B. acidifa-
ciens had the longest median survival times using the
Kaplan-Meier survival analysis. Bacteroidetes, including
B. acidifaciens, have been proposed to produce the
metabolic end products acetate, succinate, and possibly
propionate, but not butyrate [15, 16]. High acetate levels
could act as a substrate for butyrate production, given
that acetate is necessary for butyrate production,
particularly in the butyryl-CoA:acetate CoA-transferase
pathway [23, 24]. We speculate that the faecal butyrate
levels could have been enhanced due to cross-feeding of
butyrate-producing bacteria by B. acidifaciens. Proof-of-
concept was previously demonstrated for this by cross-
feeding butyrate-producing bacteria (Faecalibacterium
prausnitzii) and acetate-producing bacteria (Bifidobac-
terium adolescentis) [25]. Of note, Ramirez-Farias et al.
showed that inulin increased both Faecalibacterium
prausnitzii and Bifidobacterium adolescentis in a human
volunteer study [26].
A modified gut microbiota can augment the efficacy of
anti-tumoural treatment. However, most studies to date
are limited to chemotherapy and immunotherapy,
reviewed in [27, 28]. Recently, Herranz et al. found that
depletion of gram-positive bacteria in the gut by vanco-
mycin enhanced radiotherapy-induced anti-tumour im-
mune response and further delayed tumour growth.
However, the authors gave very large 21-Gy single frac-
tion irradiation doses. Furthermore, reductions in abun-
dance/absence of gram-negative bacteria (including
Bacteroides and S24-7) were also seen, with increased
Parabacteroides, which could be of significance. Here,
we only gave a 6-Gy single fraction of IR which is more
clinically relevant, and our findings were not immuno-
logically mediated via T cells, as CD1 nude mice lack T
cells.
To our knowledge, ours is the first study to provide
evidence that a high soluble fibre diet, and its subse-
quent modification of the gut microbiome, can act to
radiosensitise tumours.
Furthermore, B. acidifaciens was identified as a poten-
tial radiosensitiser because its abundance was enhanced
by a high soluble fibre diet and positively correlated with
tumour response to radiation and survival time in the IR
cohort. This bacterium was first isolated in 2000 and
was so named because it reduces the pH level of
peptone-yeast broth with Fildes’ digest [13]. Consistent
with our findings, Marques et al. demonstrated that a
high-fibre diet markedly increased the prevalence of B.
acidifaciens [29]. Another study showed B. acidifaciens
to be enriched in normal human subjects, compared to
patients with inflammatory bowel disease [30], and B.
acidifaciens increased insulin sensitivity and prevented
further obesity [31]. However, the effect of these bacteria
on tumour growth is still controversial. A study found
increased B. acidifaciens abundance associated with he-
patocellular carcinoma induced by a streptozotocin-high
fat diet [32]. In contrast, B. acidifaciens reduces the iso-
flavone genisten, which is associated with increased risk
of breast cancer [33], and B. acidifaciens was shown to
contribute to the anti-tumour effect of medicinal Gynos-
temma saponins [34]. In this study, we revealed that bac-
terial supernatant from B. acidifaciens and its cross-
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feeding with L. plantarum caused significantly higher
levels of cytotoxicity compared to the other supernatants
(Fig. 5k and Additional file 1: Figure S5B). This result
supports our finding that B. acidifaciens may drive the
radiosensitising effect. Moreover, B. acidifaciens in vitro
has a greater effect on cell kill than L. plantarum (lact-
ate-producer; p < 0.001), implying that metabolites other
than lactate may be involved in its effect. Studies sug-
gest that a broad range of gut microbiota-derived metab-
olites can enhance anti-tumoural effects or tumour
response to anti-cancer treatments [35–37], so future
work should include undertaking a global metabolomic
analysis of B. acidifaciens-produced metabolites to iden-
tify radiosensitisers other than SCFAs with similar
profiles.
We also found Bacteroidales S24-7 (or Candidatus
Homeothermaceae [38] or Muribaculaceae [39]), an un-
cultured bacterium with limited characterisation, to be
highly abundant in our study, especially in the mixed HF
and soluble HF groups. The prevalence of this bacterium
in humans is 20% [38]. However, increased prevalence of
Bacteroidales S24-7 of up to 70% has been shown in the
Hadza tribe of Tanzania who consume tubers containing
large amounts of soluble fibre [38]. This indicates that
high abundance of Bacteroidales S24-7 found in this
study when the tumours reached 350 mm3 might be in-
duced by soluble high fibre.
Environmental contamination is an inevitable issue in
microbiome studies [40]. To minimise the influence of
contamination in this study, bacterial loads of samples
were quantified and appropriate negative controls were
included. Bacterial loads from luminal contents and
tissue samples contained more than 104 CFUs which
overrode the environmental bacteria communities. Fur-
thermore, the bacterial compositions of the PBS negative
controls were very different from those of the study
groups, so the environmental microbiome was consid-
ered not to be a major source of bias in this study.
Although a strong correlation between B. acidifaciens
abundance and tumour response to irradiation was seen,
a limitation of this study is that only one cohort of mice
was studied. Further studies are needed to determine the
causal relationship between B. acidifaciens and radiosen-
sitisation, and its underlying aetiology. This could be
achieved by oral gavage of B. acidifaciens with or with-
out other bacteria in gnotobiotic mice and in vitro cul-
ture studies of B. acidifaciens. As both gut bacteria [41]
and irradiation [42] directly interact with the immune
system, further in vivo studies need to be conducted in
an immune-competent model to reveal how immuno-
modulation might contribute to the radiosensitisation.
Conclusion
A high soluble fibre diet increased responses of RT112
subcutaneous xenografts in CD1 nude mice to ionising
radiation, and this phenotype was associated with higher
relative abundance of B. acidifaciens. Possible mechanisms
mediating this effect, which require further investigation,
include the following: (1) increased concentrations of me-
tabolites, including butyrate or other short-chain fatty
acids in tumours, acting via HDAC inhibition or via other
pathways; (2) suppression of overgrowth of unfavourable
bacteria, such as Parabacteroides genus; and/or (3) en-
hancement of anti-tumoural immunity. Our findings sug-
gest that dietary fibre modification and the resultant
modification of the gut microbiome might be exploited to
improve tumour responses to radiotherapy in human
patients.
Methods
Mice and mouse diets
All animal work was done in accordance with UK Home
Office Guidelines, following the ARRIVE (Animal Re-
search: Reporting of In Vivo Experiments) guidelines,
and approved by the University of Oxford Animal
Welfare and Ethical Review Body (AWERB), under
University of Oxford project licences P4B738A3B and
P8484EDAE. Group sizes were chosen to detect large ef-
fect sizes by using a G-Power analysis program. All mice
were purchased from Charles Rivers UK Ltd.
CD1 nude female mice at 6–7 weeks old were housed
in a temperature-controlled environment with a 12-h
reversed-phase light/dark cycle (lights on 21:00 h) and
provided with food and water ad libitum. These mice are
immunodeficient, lacking a thymus, and therefore unable
to produce T cells. Mice were randomised in Excel using
the RAND function into four groups. At 7 to 8 weeks of
age, mice were injected subcutaneously with RT112
bladder cancer cells (DSMZ, Germany) and started re-
ceiving either a low-fibre diet (2 g cellulose/3850 kcal), a
high insoluble fibre diet (100 g cellulose/3850 kcal), a
high soluble fibre diet (100 g inulin/3850 kcal), or a high
mixed fibre diet (50 g cellulose + 50 g inulin/3850 kcal)
for a maximum time of 9 weeks or until they were culled
when the tumours reached 350 mm3. Faeces, caecal con-
tents, and proximal and distal colons from the first co-
hort were taken when the tumour reached 50mm3 (each
group n = 3) without irradiation to investigate the micro-
biome at baseline. Faeces and caecal contents from the
second cohort were taken when the tumour reached
350 mm3 after IR (each group n = 8) or without IR (each
group n = 3) or at the end of study (9 weeks after xeno-
graft) to study the association between the gut micro-
biome composition and tumour response.
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Xenograft model and irradiation method
Mice were injected subcutaneously under anaesthesia
into the right flank with 5 × 106 human bladder cancer
cells (RT112) in RPMI medium (Sigma-Aldrich) with
phenol red-free Matrigel (BD Biosciences) at a total vol-
ume of 100 μL (1:1 ratio cell suspension to Matrigel).
Tumour growth was measured three times a week, and
size determined by callipers using length × width ×
height ×Π/6. To assess the effects of different dietary
fibres on tumour growth after irradiation in vivo, mice
received ionising radiation to the tumour (6 Gy, single
fraction, 300 kV, using a Gulmay-320 cabinet irradiator,
Xstrahl Inc., UK). A dose of 6 Gy was chosen due to the
promising effect in our previous radiosensitisation ex-
periments with a HDAC inhibitor (manuscript in
preparation.)
Microbiome sample collection and DNA extraction
All samples were transported on ice and kept at − 20 °C
for less than 2 h before DNA extraction. Bacterial gen-
omic DNA was extracted using a DNeasy PowerSoil
DNA Isolation Kit (QIAGEN Ltd., Manchester, UK), as
per the Human Microbiome Project [43]. Briefly, by add-
ing sodium dodecyl sulphate (SDS), microbial cells were
lysed by mechanical disruption with a ceramic bead set
on 3000 rpm for 10 min, followed by binding of DNA
tightly to a silica membrane in a Spin Filter device at
high salt concentrations. Eventually, DNA was collected
into sterile elution buffer and quantified using a Nano-
Drop spectrophotometer. All DNA samples were kept at
− 80 °C. All samples were collected and handled in sterile
containers and equipment to minimise contamination.
Those sent for sequencing (Omega Bioservices, Georgia,
USA) were dried in an Eppendorf concentrator 5301
(Eppendorf North America Inc., USA) at a rotational
speed of 1400 rpm and centrifugal force of 240×g for 1 h
at 30 °C.
Faecal butyrate level quantification
Faecal samples were first homogenised in ice cold Milli-
pore Synergy purified water. Thereafter, 20 μL of sample
or standard was taken and 10 μL of internal standard
(valeric acid, Alfa Aesar, UK) added prior to the addition
of 5 μL 15% percholoric acid. Samples were mixed and
centrifuged at 12,000g for 15 min at 4 °C followed by
direct injection (10 μL) of the supernatant. High-
performance liquid chromatography (HPLC) separation
was carried out using a Waters Acquity H-Class Quar-
ternary Solvent Manager with mobile phases of 0.1% for-
mic acid in water (A) and methanol (B) and a gradient
of 35–75% B on a Waters Acquity CSH C18, 1.7 μm,
100 × 2.1 column. Butyrate and internal standard (IS)
were detected by mass spectrometry with a Waters
Acquity TQ detector in positive electrospray ionisation
mode. Butyrate was detected with a cone voltage of 20 V
at selected ion recording (SIR) of m/z 88.41 (M+H) and IS
with a cone voltage of 15 V and SIR of m/z 103.2 (M+H).
Cell line, drugs, and irradiator
The RT112 bladder carcinoma cell line was obtained
from the American Type Culture Collection. This cell
line was cultured in RPMI-1640 medium (Sigma), sup-
plemented with 10% foetal bovine serum (Invitrogen).
Mycoplasma testing was negative. Sodium acetate, so-
dium propionate, and sodium butyrate were purchased
from Sigma-Aldrich (Gillingham, UK) and used in
dH2O. Cells were irradiated in complete medium at a
dose rate of 1.5 Gy/min using a Gamma-Service Medical
GmbH GSR D1 irradiator.
Bacterial strain and its supernatant
All bacterial strains were obtained from DSMZ-German
collection of microorganisms. Three strains of bacteria,
namely B. acidifaciens (BA; DSM 15896), Bifidobacter-
ium animalis (Bif; DSM10140), and L. plantarum ( ),LP
and two cross-feeding combinations (BA+LP and
Bi f+LP ) were cultured in Gifu Anaerobic Broth,
Modified (GAM; Nissui Pharmaceutical, Japan). Medium
broth was prepared anaerobically in a Coy anaerobic
chamber (Coylabs, US, N2 95%, H2 5%) and sealed into
10-mL glass tubes before being autoclaved at 121 °C for
15 min. Bacteria (106 CFU/mL starting population for
each strain) were inoculated into these sealed tubes as-
cetically by injecting through a needle. They were then
placed in a 37 °C incubator for 24 h with constant shak-
ing. Samples were centrifuged at 4000×g for 10 min to
remove all particulate matter. Supernatants were then
filtered through a 0.22-μm polyethersulfone syringe filter
(Millipore).
Colony formation assay
Cells were seeded in 6-well plates at appropriate dens-
ities in triplicate; treated with short-chain fatty acids,
namely acetate, propionate, and butyrate, at appropriate
concentrations for 24 h; and irradiated with 0, 2, 4, 6,
and 8 Gy. After culturing for 10 days, colonies were fixed
and stained with 0.5% crystal violet in dH2O and 20%
methanol for 5 min. Finally, they were quantified using a
GelCount colony counter (Oxford Optronix). The sur-
viving fraction was calculated by normalising the num-




lium bromide assay was applied to assess cell viability by
adding 0.25 mg/mL MTT (Life Technologies) to cells at
37 °C for 1 h in the end of experiment. The absorbance
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at 595 nm of MTT-formazan was detected spectrophoto-
metrically using POLARstar Omega Microplate Readers
(BMG Labtech) after dissolution of the crystals in iso-
propanol. The percentage of cell viability was calculated
by the formula: [Experimental group/Control group] ×
100%.
Western blots
Western blot samples were prepared as described in
[44]. Protein was visualised using the following anti-
bodies: H3K18Ac (Cell Signaling Technology, #9675),
H3 (Cell Signaling Technologies, #4499S), and β-actin
(Abcam, #A1978), and an infrared LiCor Odyssey im-
aging system (LiCor Biosciences).
Identification and quantification of bacterial DNA
The microbiota of the contents of the intestinal tracts
and the intestinal wall of the proximal and distal colon
(tissue) was quantified by PCR of 16S rRNA. This was
performed on genomic DNA extracted as described
above. The PCR was performed using primers—V3F
(CCAGACTCCTACGGGAGGCAG) and V3R (CGTA
TTACCGCGGCTGCTG) [45]. All primers were pur-
chased from Sigma. For each sample, Phire Tissue Direct
PCR Master Mix (Thermo Fisher Scientific) was used to
amplify the 16S rRNA gene hypervariable V3 region
(product size = 200 bp). PCR amplifications were per-
formed using the following conditions: 98 °C for 5 min
followed by 35 cycles at 98 °C for 5 s each, 66.3 °C for 5 s,
and 72 °C for 30 s and a final extension step at 72 °C for
1 min. The amplification products were visualised on a
1% agarose gel after electrophoretic migration of 5 μL of
amplified material. A standard curve was created from
serial dilutions of Escherichia coli from 1 × 102, 1 × 104,
and 1 × 106 colony-forming units (CFUs) which was
quantified by CFU assay. All samples were run in dupli-
cate. In CFU assay, 20 μL of serial dilution of E. coli was
incubated onto Luria-Bertani (LB) agar plates, and col-
onies were counted and bacterial concentrations of the
original samples were estimated after 24 h incubation.
Bacterial 16S rRNA gene sequencing
16S rRNA gene sequencing methods were adapted from
the methods developed for the NIH-Human Microbiome
Project [43, 46]. Raw 16S rRNA reads and metadata have
been made available in Figshare (https://figshare.com/
projects/The_gut_microbiota_may_drive_the_radiosensi-
tising_effect_of_a_high_fibre_diet/68393) [47]. The amp-
lification and sequencing of 16S rRNA gene V3V4
region were done commercially by Omega Bioservices
(Georgia, USA) on a MiSeq platform (Illumina, Inc., San
Diego, CA) using the 2 × 300 bp paired-end protocol,
yielding paired-end reads with near-complete overlap.
The primers containing adapters for Miseq sequencing
were used for amplification and single-end barcodes,
allowing pooling and direct sequencing of PCR products
[48]. PBS negative controls were included to eliminate
the confounding effects of environmental contamination.
All 16S rRNA gene-based metagenomic analysis was
conducted using a QIIME2 platform [49]. Quality fil-
tered sequences with > 97% identity were clustered into
bins known as operational taxonomic units (OTUs),
using open-reference OTU picking. The relative abun-
dance of each OTU was obtained from all samples. In
the taxonomic analysis, the microbiome at the phylum,
class, order, family, genus, and species levels was classi-
fied with reference to the Greengenes database [50].
The analysis pipeline was as follows:
i. All sequences were trimmed to a length of 240,
since the quality dropped above this length based
on the sequence quality plots.
ii. De-noised sequencing errors by using the “Deblur”
plugin in QIIME2 [51].
iii. Taxonomic assignment was performed with
Greengenes [52] by the “feature-classifier”
command.
iv. To visualise the differences in microbial composition
between gut contents and tissue, a taxonomic profile
was generated by conducting differential abundance
analysis using balances in gneiss.
v. To identify the features characterising the differences
between groups, the LEfSe method of analysis was
performed to compare abundances of all bacterial
clades [53]. By validation using the Kruskal-Wallis
test at the α setting of 0.05, effect size was obtained
by LDA (linear discriminant analysis) based on the
significantly different vectors resulting from the com-
parison of abundances between groups.
vi. To validate the significance of enrichment of
bacterial taxa among different groups, discrete false-
discovery rates (DS-FDR) were calculated [54].
vii. A phylogenetic tree was generated by using the
“phylogeny” plugin in QIIME2.
viii.To investigate the alpha and beta diversity, the
diversity commands of “alpha-group-significance”
and “beta-group-significance” were used to obtain
Shannon’s index and the Bray-Curtis dissimilarity.
A principal coordinate (PCoA) plot was obtained by
using the Emperor Tool based on the results of the
Bray-Curtis dissimilarities.
ix. The OTU table was rarefied using the “alpha-
rarefraction” command in QIIME2. The alpha
rarefraction plot showed the richness of the
samples with increasing sequence count.
x. To predict the metagenome functional profiles,
PICRUSt, a bioinformatics software package, was
used to collapse predicted functions (KEGG
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Orthology; KO) based on 16S rRNA surveys into
higher categories (KEGG pathway) after picking
OTUs and normalisation [55].
Statistics
Power calculations for the number of mice per group
were done using G*Power software version 3.1.9.4 [56].
Alpha diversity and relative abundance of specific bac-
terial taxa were compared using the Kruskal-Wallis test
following by Dunn’s multiple comparison test. All mice
were classified into high, intermediate, or low diversity
groups based on tertiles of distribution. Time to treble
in volume was defined as the interval (in days) from the
date of irradiation (growth to 50mm3) to the date for
the tumour to treble in volume. Tumour growth curves
were analysed for each group, and their slopes were
compared using one-way ANOVA. The LEfSe method
of analysis was applied to determine the difference in
bacterial taxa, using the Kruskal-Wallis test. Significantly
different taxa presented from the previous comparison
applying LEfSe method were used as input for LDA,
which produced an LDA score. Volcano plots showed
the significance of the taxa which are different among
different groups, with log10 (FDR-adjusted p values) on
the y-axis and median-adjusted effect sizes on the x-axis.
In addition, mice were also classified as having high,
intermediate, and low abundance of B. acidifaciens or
high and low abundance of Parabacteroides genus based
on the relative abundance of these taxa in the gut micro-
biome sample. All analyses were conducted in QIIME2
and GraphPad Prism version 8.0 (La Jolla, CA).
All data in in vitro studies are representative of 3 inde-
pendent biological replicates unless otherwise stated,
with results shown as mean and standard deviations.
One-way ANOVA with Dunnett’s multiple comparison
test was performed to analyse the data of Western blots
and MTT assays. Two-way ANOVA with Dunnett’s
multiple comparison test was used to analyse the linear
quadratic survival curves in colony formation assay.
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